New medicines generate €52bn in socioeconomic value for Ireland, says WifOR study for IPHA

Ground-breaking analysis shows more than 1.4m fewer years of life are lost over 20 years due to innovative new medicines for cancer, heart diseases and respiratory diseases

Innovative new medicines for cancer, heart diseases and respiratory diseases are generating almost €52 billion in socioeconomic value for Ireland over 20 years, according to a ground-breaking new study by the WifOR Economic Research Institute for the Irish Pharmaceutical Healthcare Association (IPHA).